tradingkey.logo

Becton Dickinson and Co

BDX
201.740USD
-4.300-2.09%
Cierre 01/23, 16:00ETCotizaciones retrasadas 15 min
57.58BCap. mercado
34.58P/E TTM

Becton Dickinson and Co

201.740
-4.300-2.09%

Más Datos de Becton Dickinson and Co Compañía

Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.

Información de Becton Dickinson and Co

Símbolo de cotizaciónBDX
Nombre de la empresaBecton Dickinson and Co
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)
Número de empleados72000
Tipo de seguridadOrdinary Share
Fin del año fiscalOct 31
DirecciónOne Becton Drive
CiudadFRANKLIN LAKES
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal07417-1880
Teléfono12018476800
Sitio Webhttps://www.bd.com/
Símbolo de cotizaciónBDX
Fecha de salida a bolsaOct 31, 2099
Director ejecutivoPolen (Thomas E)

Ejecutivos de Becton Dickinson and Co

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-678480.00%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
60.06K
+194.00%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+7798.00%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+3005.00%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+117.00%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+2650.00%
Mr. Robert Andrew (Andy) Eckert
Mr. Robert Andrew (Andy) Eckert
Independent Director
Independent Director
9.29K
+148.00%
Ms. Michelle Quinn
Ms. Michelle Quinn
Executive Vice President, General Counsel
Executive Vice President, General Counsel
6.93K
+1972.00%
Mr. Gregory J. Hayes
Mr. Gregory J. Hayes
Independent Director
Independent Director
6.06K
+10.00%
Dr. Carrie L. Byington, M.D.
Dr. Carrie L. Byington, M.D.
Independent Director
Independent Director
5.54K
+294.00%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Richard (Rick) Byrd
Mr. Richard (Rick) Byrd
Executive Vice President, President - Interventional Segment
Executive Vice President, President - Interventional Segment
83.06K
-678480.00%
Mr. Timothy M. (Tim) Ring
Mr. Timothy M. (Tim) Ring
Independent Director
Independent Director
60.06K
+194.00%
Ms. Shana Carol Neal
Ms. Shana Carol Neal
Chief People Officer, Executive Vice President
Chief People Officer, Executive Vice President
54.82K
+7798.00%
Mr. Roland Goette
Mr. Roland Goette
Executive Vice President, President - EMEA
Executive Vice President, President - EMEA
17.21K
+3005.00%
Ms. Catherine M. (Cathy) Burzik
Ms. Catherine M. (Cathy) Burzik
Independent Director
Independent Director
14.92K
+117.00%
Mr. Antoine C. Ezell
Mr. Antoine C. Ezell
Executive Vice President, President, North America, Chief Marketing Officer
Executive Vice President, President, North America, Chief Marketing Officer
11.97K
+2650.00%

Desglose de ingresos

Divisa: USDActualizado: mar., 6 de ene
Divisa: USDActualizado: mar., 6 de ene
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Medication Delivery Solutions
4.58B
20.95%
Medication Management Solutions
3.47B
15.91%
Pharmaceutical Systems
2.32B
10.64%
Peripheral Intervention
2.00B
9.14%
Specimen Management
1.87B
8.57%
Otro
7.60B
34.80%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
12.79B
58.56%
International
9.05B
41.43%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Medication Delivery Solutions
4.58B
20.95%
Medication Management Solutions
3.47B
15.91%
Pharmaceutical Systems
2.32B
10.64%
Peripheral Intervention
2.00B
9.14%
Specimen Management
1.87B
8.57%
Otro
7.60B
34.80%

Estadísticas de accionistas

Actualizado: sáb., 15 de nov
Actualizado: sáb., 15 de nov
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.34%
T. Rowe Price Investment Management, Inc.
5.70%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.87%
First Eagle Investment Management, L.L.C.
3.51%
Otro
69.40%
Accionistas
Accionistas
Proporción
The Vanguard Group, Inc.
11.34%
T. Rowe Price Investment Management, Inc.
5.70%
BlackRock Institutional Trust Company, N.A.
5.18%
State Street Investment Management (US)
4.87%
First Eagle Investment Management, L.L.C.
3.51%
Otro
69.40%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
48.45%
Investment Advisor/Hedge Fund
35.80%
Research Firm
3.09%
Pension Fund
2.40%
Bank and Trust
1.47%
Hedge Fund
1.43%
Sovereign Wealth Fund
1.36%
Individual Investor
0.39%
Insurance Company
0.32%
Otro
5.29%

Participación institucional

Actualizado: lun., 8 de dic
Actualizado: lun., 8 de dic
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q4
2786
268.89M
98.17%
+69.96K
2025Q3
2887
268.83M
99.00%
+3.34M
2025Q2
2905
265.92M
96.81%
+120.40K
2025Q1
2872
266.25M
96.81%
-11.23M
2024Q4
2862
265.61M
95.72%
+1.13M
2024Q3
2775
265.14M
93.34%
+4.39M
2024Q2
2770
259.79M
92.17%
+1.30M
2024Q1
2779
258.85M
91.59%
-5.84M
2023Q4
2763
257.96M
92.19%
-5.24M
2023Q3
2735
263.83M
91.15%
+1.97M
Ver más

Actividad de los accionistas

Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
The Vanguard Group, Inc.
32.31M
11.34%
+141.20K
+0.44%
Sep 30, 2025
T. Rowe Price Investment Management, Inc.
16.23M
5.7%
+54.11K
+0.33%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
14.77M
5.18%
-380.62K
-2.51%
Sep 30, 2025
State Street Investment Management (US)
13.87M
4.87%
+459.22K
+3.42%
Sep 30, 2025
First Eagle Investment Management, L.L.C.
10.00M
3.51%
+1.21M
+13.74%
Sep 30, 2025
MFS Investment Management
8.29M
2.91%
+603.09K
+7.85%
Sep 30, 2025
Geode Capital Management, L.L.C.
6.83M
2.4%
+107.78K
+1.60%
Sep 30, 2025
Wellington Management Company, LLP
5.23M
1.84%
+5.17M
+9056.29%
Sep 30, 2025
Putnam Investment Management, L.L.C.
5.06M
1.78%
+4.13M
+441.23%
Sep 30, 2025
ClearBridge Investments, LLC
4.39M
1.54%
+588.28K
+15.47%
Sep 30, 2025
Ver más

ETFs relacionados

Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
iShares U.S. Medical Devices ETF
4.25%
FPA Global Equity ETF
3.12%
Cullen Enhanced Equity Income ETF
3.1%
American Century Focused Large Cap Value ETF
3.04%
iShares Large Cap Value Active ETF
2.72%
First Eagle Global Equity ETF
2.66%
Franklin ClearBridge Enhanced Income ETF
2.66%
T Rowe Price Capital Appreciation Equity ETF
2.65%
Brandes US Value ETF
2.26%
First Trust Indxx Medical Devices ETF
1.92%
Ver más
iShares U.S. Medical Devices ETF
Proporción4.25%
FPA Global Equity ETF
Proporción3.12%
Cullen Enhanced Equity Income ETF
Proporción3.1%
American Century Focused Large Cap Value ETF
Proporción3.04%
iShares Large Cap Value Active ETF
Proporción2.72%
First Eagle Global Equity ETF
Proporción2.66%
Franklin ClearBridge Enhanced Income ETF
Proporción2.66%
T Rowe Price Capital Appreciation Equity ETF
Proporción2.65%
Brandes US Value ETF
Proporción2.26%
First Trust Indxx Medical Devices ETF
Proporción1.92%

Dividendos

Un total de 5.54B USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Nov 06, 2025
BDX.NB Final Cash Dividend of gross USD 1.05 paid on Dec 31, 2025 going ex on Dec 08, 2025
Dec 08, 2025
Dec 31, 2025
Dec 08, 2025
Jul 22, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Sep 30, 2025 going ex on Sep 08, 2025
Sep 08, 2025
Sep 30, 2025
Sep 08, 2025
Apr 29, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Jun 30, 2025 going ex on Jun 09, 2025
Jun 09, 2025
Jun 30, 2025
Jun 09, 2025
Jan 28, 2025
BDX.NB Interim Cash Dividend of gross USD 1.04 paid on Mar 31, 2025 going ex on Mar 10, 2025
Mar 10, 2025
Mar 31, 2025
Mar 10, 2025
Nov 07, 2024
BDX.NB Final Cash Dividend of gross USD 1.04 paid on Dec 31, 2024 going ex on Dec 09, 2024
Dec 09, 2024
Dec 31, 2024
Dec 09, 2024
Jul 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Sep 30, 2024 going ex on Sep 09, 2024
Sep 09, 2024
Sep 30, 2024
Sep 09, 2024
Apr 30, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Jun 28, 2024 going ex on Jun 10, 2024
Jun 10, 2024
Jun 28, 2024
Jun 10, 2024
Jan 23, 2024
BDX.NB Interim Cash Dividend of gross USD 0.95 paid on Mar 29, 2024 going ex on Mar 07, 2024
Mar 08, 2024
Mar 29, 2024
Mar 07, 2024
Nov 09, 2023
BDX.NB Final Cash Dividend of gross USD 0.95 paid on Dec 29, 2023 going ex on Dec 07, 2023
Dec 08, 2023
Dec 29, 2023
Dec 07, 2023
Jul 25, 2023
BDX.NB Interim Cash Dividend of gross USD 0.91 paid on Sep 29, 2023 going ex on Sep 07, 2023
Sep 08, 2023
Sep 29, 2023
Sep 07, 2023
Ver más

División de acciones

Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
KeyAI